William Woods
Stock Analyst at B. Riley Securities
(1.55)
# 3,445
Out of 5,182 analysts
15
Total ratings
43.75%
Success rate
-5.26%
Average return
Main Sectors:
Stocks Rated by William Woods
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EQ Equillium | Initiates: Buy | $6 | $2.02 | +197.03% | 1 | Apr 16, 2026 | |
| KRMD KORU Medical Systems | Maintains: Buy | $7 → $8 | $4.02 | +99.00% | 2 | Mar 13, 2026 | |
| ALT Altimmune | Maintains: Buy | $18 → $13 | $2.63 | +394.30% | 1 | Mar 6, 2026 | |
| PALI Palisade Bio | Initiates: Buy | $7 | $1.96 | +258.06% | 1 | Jan 9, 2026 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $560 → $670 | $514.93 | +30.11% | 1 | Dec 11, 2025 | |
| OKYO OKYO Pharma | Initiates: Buy | $5 | $1.58 | +216.46% | 1 | Dec 8, 2025 | |
| CGTX Cognition Therapeutics | Reiterates: Buy | $2 → $3 | $1.27 | +136.24% | 1 | Nov 21, 2025 | |
| LFMD LifeMD | Maintains: Buy | $12 → $10 | $4.46 | +124.22% | 3 | Nov 18, 2025 | |
| IMUX Immunic | Reiterates: Buy | $60 → $50 | $10.26 | +387.33% | 3 | May 23, 2025 | |
| VERU Veru Inc. | Initiates: Buy | $50 | $2.26 | +2,112.39% | 1 | May 14, 2024 |
Equillium
Apr 16, 2026
Initiates: Buy
Price Target: $6
Current: $2.02
Upside: +197.03%
KORU Medical Systems
Mar 13, 2026
Maintains: Buy
Price Target: $7 → $8
Current: $4.02
Upside: +99.00%
Altimmune
Mar 6, 2026
Maintains: Buy
Price Target: $18 → $13
Current: $2.63
Upside: +394.30%
Palisade Bio
Jan 9, 2026
Initiates: Buy
Price Target: $7
Current: $1.96
Upside: +258.06%
Madrigal Pharmaceuticals
Dec 11, 2025
Maintains: Buy
Price Target: $560 → $670
Current: $514.93
Upside: +30.11%
OKYO Pharma
Dec 8, 2025
Initiates: Buy
Price Target: $5
Current: $1.58
Upside: +216.46%
Cognition Therapeutics
Nov 21, 2025
Reiterates: Buy
Price Target: $2 → $3
Current: $1.27
Upside: +136.24%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $4.46
Upside: +124.22%
Immunic
May 23, 2025
Reiterates: Buy
Price Target: $60 → $50
Current: $10.26
Upside: +387.33%
Veru Inc.
May 14, 2024
Initiates: Buy
Price Target: $50
Current: $2.26
Upside: +2,112.39%